# FDA recall D-1342-2020

> **Pfizer Inc.** · Class III · drug recall initiated 2020-05-27.

## Product

Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12

## Reason for recall

Failed Dissolution Specifications

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-1342-2020
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-05-27
- **Report date:** 2020-07-01
- **Termination date:** 2023-06-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1342-2020

## Citation

> AI Analytics. FDA recall D-1342-2020. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-1342-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*